Postprandial Effects of a High Potassium Meal

NCT ID: NCT02959931

Last Updated: 2020-02-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

33 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-06-30

Study Completion Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators aim to evaluate the acute effects of potassium supplementation achieved by ingestion of potassium rich food, on vascular health.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Many studies have shown that an increase in potassium through the diet or through potassium pills helps to lower blood pressure. Also, the amount of oral potassium taken can improve how well the participants blood vessels work. These studies have focused on potassium given in the form of a pill. The investigators are interested in the effect of potassium consumed through food sources and how it will effect arterial health and blood pressure. The world health organization (WHO) recommends a K⁺ intake of at least 3510 mg/day from food for adults, excluding those with impaired K⁺ excretion. In this study the investigators aim to provide approximately 75% (approximately 2000 mg) of the total daily recommended intake for potassium in one meal. The investigators do not know whether dietary potassium (not pill form) will acutely improve the arterial health and if it will cause a decrease in blood pressure. The investigators hypothesis to see an improvement in vascular function following a high potassium meal compared to a low potassium meal.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

High potassium meal

In this arm individuals will be provided with a breakfast meal that provides \~2400 mg of dietary potassium.

Group Type EXPERIMENTAL

High Potassium Meal

Intervention Type OTHER

Breakfast meal that provides \~2400 mg of dietary potassium. Meals are isocaloric.

Low potassium meal

In this arm individuals will be provided with a breakfast meal that provides \~540 mg of dietary potassium.

Group Type ACTIVE_COMPARATOR

Low Potassium Meal

Intervention Type OTHER

Breakfast meal that provides \~540 mg of potassium. Meals are isocaloric.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

High Potassium Meal

Breakfast meal that provides \~2400 mg of dietary potassium. Meals are isocaloric.

Intervention Type OTHER

Low Potassium Meal

Breakfast meal that provides \~540 mg of potassium. Meals are isocaloric.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18-80 years
* Normal sinus rhythm
* A diagnosis of hypertension on medical therapy with an ambulatory systolic blood pressure \<160 mmHg and diastolic blood pressure \<90 mmHg, or a diagnosis of stable coronary artery disease

Exclusion Criteria

* Recent hospital admission due to an cardiovascular events
* Serum K+ concentration \>5.0 mmol/L
* Current smoking
* Women who are pregnant
* Diabetic patients - patients receiving insulin therapy
* Glomerular filtration rate \< 90mls/min/1.73m2
* On loop diuretic therapy
* Food allergies and/or intolerance to meal items
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mount Sinai Hospital

Toronto, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MSH 13-0088-A

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.